These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15704210)

  • 1. Successful treatment of a patient with mixed warm and cold antibody mediated Evans syndrome and glucose intolerance.
    Jubinsky PT; Rashid N
    Pediatr Blood Cancer; 2005 Sep; 45(3):347-50. PubMed ID: 15704210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome.
    Rodella E; Pacquola E; Bianchini E; Ramazzina E; Paolini R
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):315-8. PubMed ID: 18469554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evans syndrome associated with idiopathic mixed-type autoimmune hemolytic anemia].
    Kakinoki Y; Nagase M; Okada K; Chiba K; Fukuhara T; Miyake T
    Rinsho Ketsueki; 2008 Jul; 49(7):516-20. PubMed ID: 18709985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases.
    Mantadakis E; Danilatou V; Stiakaki E; Kalmanti M
    Am J Hematol; 2004 Nov; 77(3):303-10. PubMed ID: 15495242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic thrombopenic purpura associated with an autoimmune hemolytic anemia or Fisher-Evans syndrome: apropos of a case].
    Ndiaye O; Sylla A; Ndiaye FS; Diagne I; Diallo-Chauvin M; Diouf S; Sallm G; Kuakuvi K
    Dakar Med; 1999; 44(2):240-2. PubMed ID: 11957294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient with mixed type Evans syndrome: efficacy of rituximab treatment.
    Park CY; Chung CH
    J Korean Med Sci; 2006 Dec; 21(6):1115-6. PubMed ID: 17179698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.
    Ramanathan S; Koutts J; Hertzberg MS
    Am J Hematol; 2005 Feb; 78(2):123-6. PubMed ID: 15682420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab therapy for childhood Evans syndrome.
    Bader-Meunier B; Aladjidi N; Bellmann F; Monpoux F; Nelken B; Robert A; Armari-Alla C; Picard C; Ledeist F; Munzer M; Yacouben K; Bertrand Y; Pariente A; Chaussé A; Perel Y; Leverger G
    Haematologica; 2007 Dec; 92(12):1691-4. PubMed ID: 18055994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
    Narat S; Gandla J; Hoffbrand AV; Hughes RG; Mehta AB
    Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up.
    Rückert A; Glimm H; Lübbert M; Grüllich C
    Lupus; 2008 Aug; 17(8):757-60. PubMed ID: 18625656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus.
    Lee JW; Kim HA; Sung JM; Suh CH
    Lupus; 2010 Feb; 19(2):227-8. PubMed ID: 19884220
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab for the treatment of autoimmune cytopenias.
    Berentsen S
    Haematologica; 2007 Dec; 92(12):1589-96. PubMed ID: 18055980
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe Evans syndrome with multi-system involvement is a distinct immunodeficiency disorder.
    Jubinsky PT; Moulton T; Tewari P; Short MK
    Pediatr Blood Cancer; 2009 May; 52(5):659-61. PubMed ID: 19127568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
    Erdozain JG; Ruiz-Irastorza G; Egurbide MV; Aguirre C
    Haematologica; 2004 Sep; 89(9):ECR34. PubMed ID: 15377486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis presented with Evans syndrome: a case report.
    Alioglu B; Avci Z; Ozyurek E; Ozbek N
    Am J Hematol; 2007 Nov; 82(11):1030-1. PubMed ID: 17626253
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained remission of CIDP associated with Evans syndrome.
    Knecht H; Baumberger M; Tobòn A; Steck A
    Neurology; 2004 Aug; 63(4):730-2. PubMed ID: 15326255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency.
    Carbone J; Escudero A; Mayayo M; Ballesteros M; Perez-Corral A; Sanchez-Ramon S; Sarmiento E; Micheloud D; Fernandez-Cruz E
    Ann N Y Acad Sci; 2005 Jun; 1051():666-71. PubMed ID: 16127007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.